MCM
AMED

MAI Capital Management’s Amedisys AMED Stock Holding History

MAI Capital Management’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-154
Closed -$15.2K – 3812
2025
Q2 		$15.2K Buy
154
+145
+1,611% +$13.7K ﹤0.01% 2500
2025
Q1 		$834 Sell
9
-3
-25% -$277 ﹤0.01% 3170
2024
Q4 		$1.09K Buy
+12
New +$1.1K ﹤0.01% 3174

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

MAI Capital Management's AMED Position: Q3 2025 in Review

MAI Capital Management sold out of Amedisys (AMED) in Q3 2025, closing a stake of 154 shares — an estimated $15.2K sold.

MAI Capital Management first reported a position in AMED in Q4 2024 and held it in 3 quarters. The position peaked at $15.2K in Q2 2025. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • MAI Capital Management reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • MAI Capital Management sold 154 Amedisys shares in Q3 2025, an estimated $15.2K.
  • MAI Capital Management first reported a position in Amedisys in Q4 2024 and held it in 3 quarters.
  • MAI Capital Management's Amedisys position peaked at $15.2K in Q2 2025.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on MAI Capital Management's 13F filing for Q3 2025, filed 10 Nov 2025.